Company Arch Therapeutics, Inc. Other OTC
Equities
ARTH
US03939W1099
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +383.80% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +383.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 15/09/09 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 09/05/21 |
Shawn Carlson
SAM | Sales & Marketing | - | 31/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 15/09/09 |
Fish Guy
BRD | Director/Board Member | 64 | 30/12/21 |
Laurence Hicks
BRD | Director/Board Member | - | 26/09/21 |
Punit Dhillon
BRD | Director/Board Member | 44 | 30/06/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,444,363 | 3,252,501 ( 73.18 %) | 0 | 73.18 % |
Company contact information
![address Arch Therapeutics, Inc.(ARTH)](https://cdn.zonebourse.com/static/address/28376861.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+14.83% | 131B | |
-8.47% | 11.05B | |
-11.46% | 7.71B | |
+37.70% | 5.67B | |
-19.26% | 4.95B | |
+7.83% | 3.43B | |
-20.16% | 2.46B | |
-15.68% | 1.97B | |
-15.34% | 1.85B |